Lilly Finalizes Novartis Animal Health Acquisition
The combined organization will increase Elanco's product portfolio, expand its global commercial presence and deliver more innovation to customers. The acquisition also augments Elanco's manufacturing and R&D capabilities with a total of 17 manufacturing sites and 14 R&D locations in the newly combined organization. Further, Elanco will have a more balanced and diversified business with revenues more evenly split between food animal and companion animal, as well as stronger geographic representation.
"As a top-tier animal health company, we are better positioned to help our customers respond to the changing external environment and meet increasing demands for animal protein, as well as growing desires for pet ownership," said
Under the terms of the agreement, Lilly acquired the
About Elanco
Elanco is a global, innovation-driven company that develops and markets products and services to improve animal health and protein production in more than 70 countries. Elanco employs more than 7,000 people worldwide, with offices in more than 40 countries, and is a division of
About
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels. C-LLY
This press release contains forward-looking statements about the benefits of the acquisition of
Refer to: |
(317) 989-2853 - |
(317) 989-7011 - | |
(317) 655-6874 - |
Logo - http://photos.prnewswire.com/prnh/20141231/166600LOGO
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lilly-finalizes-novartis-animal-health-acquisition-300014978.html
SOURCE
News Provided by Acquire Media